Literature DB >> 2612057

Proliferative responsiveness of B cells from autoimmune NZB mice to anti-immunoglobulin and interleukin-4.

M Hatakeyama1, N Minato, S Kano.   

Abstract

Proliferative responses of B cells to anti-IgM antibody and recombinant interleukin-4 (rIL-4) were studied in autoimmune NZB mice. While anti-IgM antibody and rIL-4 act synergistically on resting B cells to induce proliferation in BALB/c and C57BL/6 mice, they failed to produce synergistic effect on NZB B cells, although these NZB B cells responded better to the individual stimulus with anti-IgM antibody or rIL-4. Cell-fractionation analysis of NZB splenic B cells using Percoll density centrifugation showed marked increase in low-density B cells and decrease in high-density B cells. Proliferative response patterns of each subpopulation of NZB B cells were not different from those of control BALB/c B cells, except for higher response of NZB B cells to anti-IgM antibody. Thus, the accumulation of large low density B cells, probably resulting from in vivo activation, may partly account for the altered responsiveness of NZB B cells as a whole.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2612057      PMCID: PMC1534816     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Functional deficiency of splenic adherent cells in New Zealand black mice.

Authors:  C McCombs; J Hom; N Talal; R I Mishell
Journal:  J Immunol       Date:  1975-12       Impact factor: 5.422

2.  B cell hyperactivity in systemic lupus erythematosus: selectively enhanced responsiveness to a high molecular weight B cell growth factor.

Authors:  J F Delfraissy; C Wallon; A Vazquez; B Dugas; J Dormont; P Galanaud
Journal:  Eur J Immunol       Date:  1986-10       Impact factor: 5.532

3.  B-cell growth factor (B-cell growth factor I or B-cell-stimulating factor, provisional 1) is a differentiation factor for resting B cells and may not induce cell growth.

Authors:  K Oliver; R J Noelle; J W Uhr; P H Krammer; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1985-04       Impact factor: 11.205

4.  Sequential requirements for cell cycle progression of resting human B cells after activation by anti-Ig.

Authors:  A Muraguchi; J H Kehrl; J L Butler; A S Fauci
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

5.  Studies of congenitally immunologically mutant New Zealand mice. IX. Age-related microenvironmental effects on autoantibody production in NZB and NZB.Xid mice studied by transplantation.

Authors:  K R Bray; M E Gershwin; R R Skelly; A Ahmed; P W Kincade
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

6.  Defects in hematopoietic differentiation in NZB and NZC mice.

Authors:  N L Warner; M A Moore
Journal:  J Exp Med       Date:  1971-08-01       Impact factor: 14.307

7.  B-cell stimulatory factor 1 activates resting B cells.

Authors:  E M Rabin; J Ohara; W E Paul
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

8.  Abnormal production of and response to B-cell growth factor and B-cell differentiation factor in patients with systemic lupus erythematosus.

Authors:  T Hirose; M Hara; A Kitani; W Hirose; K Norioka; M Kawagoe; H Nakamura
Journal:  Scand J Immunol       Date:  1985-02       Impact factor: 3.487

9.  Establishment of mouse cell lines which constitutively secrete large quantities of interleukin 2, 3, 4 or 5, using modified cDNA expression vectors.

Authors:  H Karasuyama; F Melchers
Journal:  Eur J Immunol       Date:  1988-01       Impact factor: 5.532

10.  Loss of suppressor T cells in adult NZB/NZW mice.

Authors:  R S Krakauer; T A Waldmann; W Strober
Journal:  J Exp Med       Date:  1976-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.